Commission Decision of 29 June 2007 establishing the BSE status of Member States or third countries or regions thereof according to their BSE risk (notified under document number C(2007) 3114) (Text with EEA relevance) (2007/453/EC)

[F1 ANNEX U.K. LIST OF COUNTRIES OR REGIONS

Textual Amendments

F1 Substituted by Commission Implementing Decision (EU) 2017/1396 of 26 July 2017 amending the Annex to Decision 2007/453/EC as regards the BSE status of Poland and certain regions of the United Kingdom (notified under document C(2017) 5140) (Text with EEA relevance).

A. Countries or regions with a negligible BSE risk U.K.

Member States U.K.

• Belgium

• Bulgaria

• Czech Republic

• Denmark

• Germany

• Estonia

• Croatia

• Italy

• Cyprus

• Latvia

• Lithuania

• Luxembourg

• Hungary

• Malta

• Netherlands

• Austria

• Poland

• Portugal

• Romania

• Slovenia

• Slovakia

• Spain

• Finland

• Sweden

F2 ... U.K.

• F3 ...

• F3 ...

Textual Amendments

F3 Words in Annex Pt. A omitted (31.12.2020) by virtue of The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/170), regs. 1, 3(4)(a)(ii); 2020 c. 1, Sch. 5 para. 1(1)

Textual Amendments

F2 Words in Annex Pt. A omitted (31.12.2020) by virtue of The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/170), regs. 1, 3(4)(a)(i); 2020 c. 1, Sch. 5 para. 1(1)

European Free Trade Association countries U.K.

• Iceland

• Liechtenstein

• Norway

• Switzerland

Third countries U.K.

• Argentina

• Australia

• Brazil

• Chile

• Colombia

• Costa Rica

• India

• Israel

• Japan

• Namibia

• New Zealand

• Panama

• Paraguay

• Peru

• [F4 Serbia](1)

• Singapore

• United States

• Uruguay

Textual Amendments

F4 Inserted by Commission Implementing Decision (EU) 2020/919 of 30 June 2020 amending the Annex to Decision 2007/453/EC as regards the BSE status of Serbia (notified under document C(2020) 4236) (Text with EEA relevance).

B. Countries or regions with a controlled BSE risk U.K.

Member States U.K.

• Ireland

• Greece

• France

• F5 ...

Textual Amendments

F5 Words in Annex Pt. B omitted (31.12.2020) by virtue of The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/170), regs. 1, 3(4)(b); 2020 c. 1, Sch. 5 para. 1(1)

Third countries U.K.

• Canada

• Mexico

• Nicaragua

• South Korea

• Taiwan

C. Countries or regions with an undetermined BSE risk U.K.

• Countries or regions not listed in points A or B [F6 , other than the regions of the constituent nations of the British Islands, which have an official BSE risk status determined by their categorisation by the OIE].]

Textual Amendments

F6 Words in Annex Pt. C inserted (31.12.2020) by The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/170), regs. 1, 3(4)(c) (as amended by S.I. 2020/1388, regs. 1(2)(a), 20(3)); 2020 c. 1, Sch. 5 para. 1(1)

(1)

[F1 [F4 as referred to in Article 135 of the Stabilisation and Association Agreement between the European Communities and their Member States of the one part, and the Republic of Serbia, of the other part ( OJ L 278, 18.10.2013, p. 16 ).] ]

Textual Amendments

F1 Substituted by Commission Implementing Decision (EU) 2017/1396 of 26 July 2017 amending the Annex to Decision 2007/453/EC as regards the BSE status of Poland and certain regions of the United Kingdom (notified under document C(2017) 5140) (Text with EEA relevance).

F4 Inserted by Commission Implementing Decision (EU) 2020/919 of 30 June 2020 amending the Annex to Decision 2007/453/EC as regards the BSE status of Serbia (notified under document C(2020) 4236) (Text with EEA relevance).